US wants Covid vaccine patent waiver to benefit world, not boost China biotech
Skip to main content
  • Home
  • Economy
  • Stocks
  • Analysis
  • World+Biz
  • Sports
  • Splash
  • Features
  • Videos
  • Long Read
  • Games
  • Epaper
  • More
    • COVID-19
    • Bangladesh
    • Infograph
    • Interviews
    • Offbeat
    • Thoughts
    • Podcast
    • Quiz
    • Tech
    • Subscribe
    • Archive
    • Trial By Trivia
    • Magazine
    • Supplement
  • বাংলা
The Business Standard
TUESDAY, MAY 17, 2022
TUESDAY, MAY 17, 2022
  • Home
  • Economy
  • Stocks
  • Analysis
  • World+Biz
  • Sports
  • Splash
  • Features
  • Videos
  • Long Read
  • Games
  • Epaper
  • More
    • COVID-19
    • Bangladesh
    • Infograph
    • Interviews
    • Offbeat
    • Thoughts
    • Podcast
    • Quiz
    • Tech
    • Subscribe
    • Archive
    • Trial By Trivia
    • Magazine
    • Supplement
  • বাংলা
US wants Covid vaccine patent waiver to benefit world, not boost China biotech

Coronavirus chronicle

Reuters
09 May, 2021, 09:35 am
Last modified: 09 May, 2021, 09:40 am

Related News

  • US to suggest tariffs on Russian oil as alternative to embargoes
  • Iraq balks at greater Chinese control of its oilfields
  • Japan and US preparing statement promising to 'deter' China, Nikkei reports
  • Shanghai achieves 'zero Covid' status but normal life is weeks away
  • US Air Force says it conducted successful hypersonic weapon test

US wants Covid vaccine patent waiver to benefit world, not boost China biotech

Many companies and now some US officials fear the move would allow China to leapfrog years of research and erode the US advantage in biopharmaceuticals

Reuters
09 May, 2021, 09:35 am
Last modified: 09 May, 2021, 09:40 am
A man receives a dose of a coronavirus disease (Covid-19) vaccine, at a vaccination center in Karachi, Pakistan April 28, 2021. Photo: Reuters
A man receives a dose of a coronavirus disease (Covid-19) vaccine, at a vaccination center in Karachi, Pakistan April 28, 2021. Photo: Reuters

The Biden administration is examining ways to ensure that a waiver of Covid-19 vaccine patents to aid poor countries will not hand sensitive US biopharmaceutical technology to China and Russia, responding to a chorus of concerns, US and industry officials say.

President Joe Biden on Wednesday backed the US entering negotiations at the World Trade Organization for the waiver of intellectual property rights as a means to boost vaccine supplies by allowing poorer countries to make their own.

So far, vaccines have gone overwhelmingly to richer nations, which scooped up contracts for them earlier this year. Covid-19 infection rates in wealthy countries have dropped as vaccination rates increased this year, but infections are still rising in 36 countries, with India's daily cases skyrocketing to nearly 400,000 a day.

Western pharmaceutical companies, many of which have received government support to develop vaccines, strongly oppose the transfer of intellectual property to make them. They say poorer countries will be slow to set up manufacturing capacity and compete for scarce supplies, hitting production.

Albert Bourla, CEO of Pfizer Inc, said on Friday that the proposed waiver would disrupt progress made so far in boosting vaccine supplies. "It will unleash a scramble for the critical inputs we require in order to make a safe and effective vaccine. Entities with little or no experience in manufacturing vaccines are likely to chase the very raw materials we require to scale our production, putting the safety and security of all at risk."

Many companies and now some US officials fear the move would allow China to leapfrog years of research and erode the US advantage in biopharmaceuticals.

A senior Biden administration official said that while the priority is saving lives, the United States "would want to examine the effect of a waiver on China and Russia before it went into effect to ensure that it's fit for purpose."

A question and answer document produced by the administration and shared with industry representatives also acknowledges concerns that intellectual property sharing could damage the United State's competitive advantage over China, an industry source familiar with the discussions told Reuters.

The contents of the document read to a Reuters reporter by an industry representative said the Biden administration believes it can address those concerns through the WTO negotiations, but did not specify how. The source added that some agencies in the Biden administration have conflicting views of how to address the concerns in negotiations that are expected to take months.

Spokespersons at the White House and US Trade Representative's office had no immediate comment on the matter.

Pfizer and Moderna spokespersons did not respond to requests for comment on technology transfer concerns, while a Novavax spokesperson referred Reuters to the company's statement opposing the waiver on Friday, which said proposals to "weaken intellectual property protections would not achieve equitable vaccine access."

Enforcing limits on use of the technology could be very difficult, once handed over, some analysts say. Messenger RNA, used in Covid-19 vaccines by leaders Pfizer/BioNTech and Moderna, is a newly developed biotechnology that holds promise for treatments far beyond vaccines.

China and Russia have their own vaccines that do not use this biotechnology.

"It took Pfizer and Moderna years and years of research to develop these vaccines," said Gary Locke a former US ambassador to China and US Commerce Secretary. "China, Russia, India, South Africa and others want to gain access. Their intention is to get the underlying know-how so they can use it to develop further vaccines," Locke said.

China's Fosun Pharma has struck a deal with BioNTech on Covid-19 vaccine product development, which would potentially give it access to some of the technology.

China has high ambitions for its pharma industry and already is developing its own mRNA vaccine.

Patents themselves are publicly accessible, noted James Pooley, intellectual property attorney and former deputy director general of the United Nations' World Intellectual Property Organization. But trade secrets developed by Pfizer/BioNTech, Moderna and others, "cook books" of manufacturing processes such as temperature and growing conditions, have not been made public. That may ultimately be a dual problem for negotiators. Before they protect the knowledge, US officials would have to ensure access to it.

Those companies would need to be persuaded to come to the bargaining table to give up such trade secrets.

"What happens when it turns out that the US can't actually deliver the information that is critically important to implementing the inventions?" Pooley asked. "This will be seen as another failure by the US and other rich countries to keep their promises."

Top News / World+Biz

US / china

Comments

While most comments will be posted if they are on-topic and not abusive, moderation decisions are subjective. Published comments are readers’ own views and The Business Standard does not endorse any of the readers’ comments.

Top Stories

  • A packet of US five-dollar bills is inspected at the Bureau of Engraving and Printing in Washington March 26, 2015. REUTERS/Gary Cameron
    Dollar price crosses Tk100 in open market 
  • Finland's Prime Minister Sanna Marin speaks during the plenary session at the Finnish parliament in Helsinki, Finland on 16 May 2022. Photo: Reuters
    Finland's parliament votes yes to NATO
  • Govt fixes tolls for Padma Bridge
    Govt fixes tolls for Padma Bridge

MOST VIEWED

  • People watch a TV broadcasting a news report on the coronavirus disease (Covid-19) outbreak in North Korea, at a railway station in Seoul, South Korea on 17 May 2022. Photo: Reuters.
    N Korea Covid outbreak could have 'devastating' impact on human rights, UN says
  • Two women hug at a closed street during lockdown, amid the coronavirus disease (COVID-19) pandemic, in Shanghai, China, May 16, 2022. REUTERS/Aly Song
    Shanghai achieves 'zero Covid' status but normal life is weeks away
  • People wearing protective face masks commute amid concerns over the new coronavirus disease (COVID-19) in Pyongyang, North Korea March 30, 2020, in this photo released by Kyodo. Picture taken March 30, 2020. Mandatory credit Kyodo/via REUTERS
    N Korea mobilises army, steps up tracing amid Covid wave
  • Customers wait in front of a restaurant in Beijing, China April 15, 2022. REUTERS/Tingshu Wang/Files
    China's economy skids as lockdowns hit factories, retailers
  • A medical worker in a protective suit collects a swab from a resident at a makeshift nucleic acid testing site inside a residential compound under lockdown, amid the coronavirus disease (COVID-19) outbreak in Shanghai, China April 14, 2022. REUTERS/Xihao Jiang
    Shanghai aims for return to normal life from 1 June
  • South Korea's new President Yoon Suk-yeol signs a document as he works at the new Presidential office in Seoul, South Korea, May 10, 2022. Yonhap via REUTERS/File Photo
    S Korea says it will spare no effort to help North Korea amid Covid outbreak

Related News

  • US to suggest tariffs on Russian oil as alternative to embargoes
  • Iraq balks at greater Chinese control of its oilfields
  • Japan and US preparing statement promising to 'deter' China, Nikkei reports
  • Shanghai achieves 'zero Covid' status but normal life is weeks away
  • US Air Force says it conducted successful hypersonic weapon test

Features

Despite Bangladesh having about 24,000 km of waterways, only a few hundred kilometres are covered by commercial launch services. Photo: Saad Abdullah

Utilising waterways: When common home-goers show the way

7h | Panorama
Illustration: TBS

How Putin revived Nato

9h | Panorama
The reception is a volumetric box-shaped room that has two glass walls on both the front and back ends and the other two walls are adorned with interior plants, wood and aluminium screens. Photo: Noor-A-Alam

The United House: Living and working inside nature

9h | Habitat
Pcycle team members at a waste management orientation event. Photo: Courtesy

Pcycle: Turning waste from bins into beautiful crafts

10h | Panorama

More Videos from TBS

The first mosque in India was built Prophet Mohammad time

The first mosque in India was built Prophet Mohammad time

16m | Videos
After six decades ,the Archies is back

After six decades ,the Archies is back

16m | Videos
Exporters in discomfort, expatriates preferring Hundi

Exporters in discomfort, expatriates preferring Hundi

16m | Videos
Can your coworker be your closest friend?

Can your coworker be your closest friend?

10h | Videos

Most Read

1
Representative Photo: Pixabay.
Bangladesh

Microplastics found in 5 local sugar brands

2
Mushfiq Mobarak. Photo: Noor-A-Alam
Panorama

Meet the Yale professor who anchors his research in Bangladesh and scales up interventions globally

3
Impact of falling taka against US dollar
Banking

Taka losing more value as global currency market volatility persists

4
Govt tightens belt to relieve reserve
Economy

Govt tightens belt to relieve reserve

5
Union Capital asked to return Tk100cr FDR to BATBC 
Banking

Union Capital asked to return Tk100cr FDR to BATBC 

6
How Bangladesh can achieve edible oil self-sufficiency with local alternatives
Bazaar

How Bangladesh can achieve edible oil self-sufficiency with local alternatives

The Business Standard
Top
  • Home
  • Entertainment
  • Sports
  • About Us
  • Bangladesh
  • International
  • Privacy Policy
  • Comment Policy
  • Contact Us
  • Economy
  • Sitemap
  • RSS

Contact Us

The Business Standard

Main Office -4/A, Eskaton Garden, Dhaka- 1000

Phone: +8801847 416158 - 59

Send Opinion articles to - oped.tbs@gmail.com

For advertisement- sales@tbsnews.net

Copyright © 2022 THE BUSINESS STANDARD All rights reserved. Technical Partner: RSI Lab